The topic of Factor 9 concentrates was discussed in a meeting of directors of the Scottish National Blood Transfusion Service and haemophilia centre directors. It was reported that studies of heat treatment, to reduce the hepatitis risk, were currently underway using Supernine. Read more about The topic of Factor 9 concentrates was discussed in a meeting of directors of the Scottish National Blood Transfusion Service and haemophilia centre directors. It was reported that studies of heat treatment, to reduce the hepatitis risk, were currently underway using Supernine.
The topic of AIDS was discussed in a meeting of directors of the Scottish National Blood Transfusion Service and haemophilia centre directors. In the meeting, Dr Cash drew attention to recent articles in The Observer and The Lancet and circulated a MMWR extract. Read more about The topic of AIDS was discussed in a meeting of directors of the Scottish National Blood Transfusion Service and haemophilia centre directors. In the meeting, Dr Cash drew attention to recent articles in The Observer and The Lancet and circulated a MMWR extract.
Cases of AIDS in haemophilia patients in the United States were discussed in a UK Haemophilia Centre Directors Hepatitis Working Party meeting. Among the issues raised was the possibility that Factor 8 or other blood products administered to haemophilia patients "might be implicated." Read more about Cases of AIDS in haemophilia patients in the United States were discussed in a UK Haemophilia Centre Directors Hepatitis Working Party meeting. Among the issues raised was the possibility that Factor 8 or other blood products administered to haemophilia patients "might be implicated."
Alpha Pharmaceutical issued a press release, which said: "The evidence suggests, although it does not absolutely prove, that a virus or other disease agent was transmitted to them in the Factor VIII concentrate, derived from pooled human plasma." Read more about Alpha Pharmaceutical issued a press release, which said: "The evidence suggests, although it does not absolutely prove, that a virus or other disease agent was transmitted to them in the Factor VIII concentrate, derived from pooled human plasma."
Dr Cash wrote to Dr Lane expressing his view that it is not "in the best interests of the NHS Fractionation Centres, at this time, to encourage the commercial manufacturers to undertake clinical trials with a view to obtaining product licences." Read more about Dr Cash wrote to Dr Lane expressing his view that it is not "in the best interests of the NHS Fractionation Centres, at this time, to encourage the commercial manufacturers to undertake clinical trials with a view to obtaining product licences."
Dr Rizza wrote to Dr Lane to confirm arrangements made for an informal meeting to be held on 15 December 1982 at BPL to discuss hepatitis free/hepatitis reduced coagulant factor concentrate. Read more about Dr Rizza wrote to Dr Lane to confirm arrangements made for an informal meeting to be held on 15 December 1982 at BPL to discuss hepatitis free/hepatitis reduced coagulant factor concentrate.
Dr Dale Lawrence of the Centers for Disease Control in the United States wrote to Dr Craske about the US cases of AIDS among people with haemophilia. Read more about Dr Dale Lawrence of the Centers for Disease Control in the United States wrote to Dr Craske about the US cases of AIDS among people with haemophilia.
Dr Craske wrote to Dr Lane, enclosing a copy of the paper he prepared for the MRC Hepatitis Vaccine Working Group meeting, "which describes early information about AIDS in the U.S.A." Read more about Dr Craske wrote to Dr Lane, enclosing a copy of the paper he prepared for the MRC Hepatitis Vaccine Working Group meeting, "which describes early information about AIDS in the U.S.A."
Dr Craske wrote to Dr Ludlam, enclosing a copy of the paper he prepared for the MRC Hepatitis Vaccine Working Group meeting, "which describes the most recent information available about [AIDS]". Read more about Dr Craske wrote to Dr Ludlam, enclosing a copy of the paper he prepared for the MRC Hepatitis Vaccine Working Group meeting, "which describes the most recent information available about [AIDS]".
Dr Craske thought it necessary to have a meeting of the Hepatitis Working Party "to decide what further investigations need to be undertaken in the British haemophiliac population". Read more about Dr Craske thought it necessary to have a meeting of the Hepatitis Working Party "to decide what further investigations need to be undertaken in the British haemophiliac population".